Market revenue in 2024 | USD 4,517.9 million |
Market revenue in 2030 | USD 6,493.0 million |
Growth rate | 6.2% (CAGR from 2024 to 2030) |
Largest segment | Defibrillators |
Fastest growing segment | Defibrillators |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) |
Key market players worldwide | Stryker Corp, BIOTRONIK, SCHILLER, Medtronic PLC, Abbott Laboratories, Koninklijke Philips NV, ZOLL Medical Corporation, Boston Scientific Corp, LivaNova PLC, Progetti Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac rhythm management devices market will help companies and investors design strategic landscapes.
Defibrillators was the largest segment with a revenue share of 43.75% in 2024. Horizon Databook has segmented the Europe cardiac rhythm management devices market based on pacemakers, defibrillators, cardiac resynchronization therapy (crt) covering the revenue growth of each sub-segment from 2018 to 2030.
According to the European Commission, cardiovascular system diseases significantly burden government budgets and healthcare systems. In 2020, 1.70 million deaths were reported in the EU from cardiovascular system diseases, which was equivalent to 32.7 % of all deaths. Moreover, according to the European Commission, SCAs account for approximately 20% of the deaths in the region.
These factors are expected to support market growth in the region. Moreover, the launch of new CRDMs in Europe is expected to drive the market due to the increasing prevalence of cardiovascular diseases and the rise in the geriatric population.
These new devices offer improved accuracy & efficiency in monitoring and treating cardiac rhythm disorders. In addition, technological advancements and increasing investments in R&D by key players in the industry are expected to drive market growth further.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe cardiac rhythm management devices market, including forecasts for subscribers. This continent databook contains high-level insights into Europe cardiac rhythm management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account